Apyx Medical (APYX) Receivables - Net (2010 - 2026)

Apyx Medical's Receivables - Net history runs 17 years deep, the most recent figure standing at $12.8 million for Q1 2026.

• Quarterly Receivables - Net rose 9.53% year-over-year to $12.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.8 million (up 9.53% YoY) and the FY2025 annual result came in at $16.8 million, up 8.37% from the prior year.
• Receivables - Net was $12.8 million for Q1 2026 at Apyx Medical, down from $16.8 million in the prior quarter.
• Across five years, Receivables - Net topped out at $16.8 million in Q4 2025 and bottomed at $500000.0 in Q4 2023.
• A 5-year average of $11.6 million and a median of $12.4 million in 2022 frame the typical range for Receivables - Net.
• Annual changes were most pronounced in 2023 — Receivables - Net sank 95.28% — and 2024, when it jumped 2996.0%.
• Apyx Medical's Receivables - Net stood at $10.6 million in 2022, then sank by 95.28% to $500000.0 in 2023, then soared by 2996.0% to $15.5 million in 2024, then increased by 8.37% to $16.8 million in 2025, then declined by 23.97% to $12.8 million in 2026.
• Business Quant data shows APYX's Receivables - Net at $12.8 million in Q1 2026, $16.8 million in Q4 2025, and $13.0 million in Q3 2025.